Study in Patients With Onychomycosis Treated With Mycoclear® and Ciclopirox

The goal of this study is to learn about the effectiveness and safety of two products, ciclopirox or Mycoclear®, in treating fungal infections. People with fungal infections of the nails and over the age of 18 were treated at the Department of Dermatology, IRCCS Azienda Ospedaliero - Universitaria Sant'Orsola in Bologna (Italy) between January 1, 2019, and April 30, 2023. The people were treated as part of their regular medical care with ciclopirox or Mycoclear®. In this observational study, the data are now being reviewed to answer the following questions: • Does Mycoclear® work as well as ciclopirox for fungal nail infections, when used for up to 24 weeks? People were seen at the beginning for an initial assessment, and then again at two, four, 12, and 24 weeks. The doctor did the following main tests during the study period: * Performing the clinical evaluation * Checking the lab test for a fungal infection. * Measuring how much of the nail grows without problems. The results of this study will help dermatologists choose the best treatment for fungal nail infections.

NCT Number	NCT06971341
Lead Sponsor	University of Bologna Collaborators: Dionisio Franco Barattini, MD, MBA, MSc
Conditions	Onychomycosis of Toenails
Enrollment	80 participants
Start Date	2025-05-30
Primary Completion	2025-12-30 (estimated)
Study Completion	2025-12-30 (estimated)
Updated on ClinicalTrials.gov	2025-05-20